Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Felcisetrag in diabetic or idiopathic gastroparesis
NCT03281577Phase 2Completed
- Sponsor
- Takeda
- Start
- Jan 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of felcisetrag in diabetic gastroparesis, idiopathic gastroparesis (IG), sponsored by Takeda. Started Jan 2018; status: completed.
02
Drugs
felcisetrag
03
Conditions
diabetic gastroparesisidiopathic gastroparesis (IG)
Beyond the preview
Go deeper on NCT03281577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03281577.